Cytokinetics Inc Earnings

Cytokinetics Inc’s revenue jumped 89.1% since last year same period to $1.58Mn in the Q1 2025. On a quarterly growth basis, Cytokinetics Inc has generated -90.67% fall in its revenue since last 3-months.

Cytokinetics Inc’s net profit fell -18.97% since last year same period to $-161.38Mn in the Q1 2025. On a quarterly growth basis, Cytokinetics Inc has generated -7.57% fall in its net profits since last 3-months.

Cytokinetics Inc’s net profit margin jumped 37.09% since last year same period to -10220.14% in the Q1 2025. On a quarterly growth basis, Cytokinetics Inc has generated -1053.15% fall in its net profit margins since last 3-months.

Cytokinetics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.46 - a -2.82% fall from last quarter’s estimates.

Cytokinetics Inc’s earning per share (EPS) estimates for the current year stand at -1.46.

Cytokinetics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Cytokinetics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.